Filing Flows › Carlsmed (CARL) › Q1 2026 › vs Q1 2025
Carlsmed (CARL) Q1 2026 vs Q1 2025 (year over year)
Carlsmed's revenue rose $5.9M (+58%) from $10.2M in Q1 2025 to $16.1M in Q1 2026.
Carlsmed, Q1 2026: revenue $16.1M (+58% year over year), operating margin -57.6%, net loss $8.7M, operating cash flow −$13.0M. The chart draws each line against Q1 2025, the increases inside each band.
Every line
| Line | Q1 2026 | Q1 2025 | Change | % |
|---|---|---|---|---|
| Revenue | $16.1M | $10.2M | $5.9M | +58% |
| Other income, net | $580K | −$10K | $590K | — |
| Net loss | $8.7M | $5.7M | $3.0M | +52% |
| Costs & expenses | $25.4M | $15.9M | $9.5M | +60% |
| Operating costs | $25.4M | $15.9M | $9.5M | +60% |
| Cost of revenue | $3.7M | $2.6M | $1.1M | +45% |
| Research & development | $5.2M | $3.1M | $2.0M | +64% |
| Sales & marketing | $10.3M | $6.7M | $3.6M | +53% |
| General & admin | $6.2M | $3.5M | $2.8M | +80% |
| Operating cash sources | $14.7M | $8.4M | $6.4M | +76% |
| Depreciation & amortization | $99K | $40K | $59K | +148% |
| Share-based compensation | $1.6M | $175K | $1.5M | +831% |
| Cash used in operations | $13.0M | $8.2M | $4.9M | +59% |
| Net loss absorbed | $8.7M | $5.7M | $3.0M | +52% |
| Working capital & other | $6.0M | $2.6M | $3.4M | +129% |
Questions
How much did Carlsmed's revenue grow year over year in Q1 2026?
Carlsmed's revenue rose $5.9M (+58%) from $10.2M in Q1 2025 to $16.1M in Q1 2026.